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1. Introduction 
The modern pharmaceutical technology is not conceivable without plasticized polymers. 
The pharmaceutical applications of polymers range from packaging materials or auxiliary 
substances in conventional dosage forms to membranes or matrices modifying and 
controlling the drug release characteristics in therapeutic systems. Recently, a great variety 
of plasticized polymeric systems have been studied as microparticles, matrices, free 
membranes, membranes for transdermal systems and in situ forming implants. Not only the 
polymer itself but thorough choice of other ingredients of the polymer system is necessary 
for required quality of drug delivery system. The plasticizer has the unsubstitutable place in 
drug polymer system due to its primary role, i. e. improve the flexibility and processability 
of polymers by lowering the glass transition temperature. The supramolecular structure and 
relevant properties of specific plasticized polymer drug delivery systems has attracted the 
interest of many researchers. 
2. Plasticized polymers used as coatings of the dosage forms 
It is common practice to coat oral solid dosage forms with polymeric materials for several 
purposes, such as modifying drug release, affording gastroprotection, protecting from 
environmental agents, masking unpleasant taste or just enhancing product aesthetics. A film 
coating is defined as a thin and uniform polymer based-layer of about 20 to 100 µm in 
thickness, which is applied to the surface of substrates such as tablets, granules, powders, 
capsules, particles or pellets (Porter, 1995). 
Polymers used in coating can be categorized into two types: (i) non-functional or 
conventional film coating polymers for immediate release coatings; which improve the 
appearance, the handling, prevent dusting or (ii) functional coating polymers, which can be 
used to modify the pharmaceutical function of the dosage forms, and include the delayed 
release dosage forms and sustained release (or extended or prolonged) dosage forms. 
Coating films can be usually prepared from organic solvent-based polymers or aqueous 
solvent-based latex dispersions. However, the aqueous film coating have been favoured in 
coating technology because of its wide applications, low environmental concerns, efficiency 
of the process, and wide commercial availability of coating materials. The cellulose ethers 
and esters are the major group of polymers used in the film coating process. The 
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pharmaceutical compositions of two kinds of coated beads were patented.  The polymer 
coatings of the beads differed in water solubility. This pharmaceutical composition 
comprised phtalates, trimellitates, adipates, sebacates, glycols, polyethers and alkyl citrates 
as the plasticizers (Paborji & Flugel 2011). 
Cellulose acetate phthalate (CAP), widely used in enteric film coating, is available as a white 
powder or also as a 30 % solid nanodispersion (pseudolatex) (Aquacoat® CPD). Polyvinyl 
acetate phthalate is less susceptible to hydrolysis, which minimizes or limits the content of 
free phthalic acid and other free acids. 
Cellulose acetate trimellitate (CAT) has three carboxylic groups on the aromatic ring and 
dissolves at a pH of 5.5. The plasticizers as triacetin, acetylated monoglyceride, diethyl 
phthalate are recommended, and to obtain the best enteric coating results from aqueous 
processing, ammoniated solutions of CAT in water are the best choice. 
Hydroxypropyl methylcellulose phthalate (HPMCP) characteristics, particularly at the pH 
where dissolution occurs, are determined by the degree of substitution of the three kinds of 
substituent groups (i.e. methoxy, hydroxypropoxy, and carboxybenzoyl). Valuable 
plasticizers include triacetin, acetylated monoglyceride and diethyl phthalate. 
Acrylic polymers as a group of various synthetic polymers, methacrylic amino ester 
copolymers, have diverse functionality in film coating. They can be used for rapidly 
disintegrating coatings, taste and odour masking, coloured or transparent coatings, etc., and 
are available mainly as the Eudragit® products. 
Methacrylic acid copolymers contain free carboxylic acid groups, and therefore can be used 
for enteric coating purposes by forming salts with alkalis. Methacrylic acid copolymers are 
soluble at pH values higher than 5.5. The addition of a plasticizer in these polymers is 
necessary. Methacrylic acid copolymers are available as various grades of Eudragit® 
products. 
2.1 The role of the plasticizer in the film coating 
The plasticizer plays the major role in the all process of the oral dosage form coating, and 
significantly influences the quality of the coatings, particularly the release of incorporated 
drugs. 
2.1.1 Film formation facilitated by plasticizer 
The film-formation mechanism from the coating dispersions is a complex process 
influenced mainly with the type and also with the quantity of plasticizer. The temperature 
below which a coating will not form a continuous, cohesive film is called the minimum 
film forming temperature; it is the minimum temperature above the Tg of the polymer. In 
order to ensure the optimum conditions for film formation, the really used coating 
temperature during the application process should be 10-20 °C above the minimum film 
forming temperature (Lehmann, 1992). Since plasticizer addition to film coating 
formulation reduces the Tg of the polymer, as a result the temperature required for film 
coating is reduced by plasticization (Zhu et al., 2002).  
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A sufficient amount of time should be allowed for the plasticizer uptake to ensure a 
homogeneous distribution of the plasticizer in the coating film. The time between the 
addition of the plasticizer to the polymer dispersion and the coating step is usually called as 
the plasticization time and presents a critical process variable, especially when water-
insoluble plasticizers are used. Water insoluble plasticizers have to be emulsified in the 
aqueous phase of the polymer dispersions. During plasticization of the polymer dispersions, 
the plasticizer partitions into the colloidal polymer particles and softens them thus 
promoting particle deformation and coalescence into a film upon drying. Commercial 
suppliers of polymer dispersions often recommend a relatively short plasticization time of 
30 - 60 minutes irrespective of the solubility of the plasticizer. Plasticizers are incorporated 
in the amorphous parts of polymers while the structure and size of any crystalline part 
remains unaffected (Fedorko et al., 2003). The thermal treatment following the application of 
the coat is known as curing. During this stage of coating, the coated dosage form is 
subjected to temperatures higher than the Tg, which facilitates uniform distribution of 
plasticizers. During curing of the coatings, plasticizers could also redistribute in the 
polymeric film.  
Controlled released pharmaceutical formulations comprising pseudoephedrine embedded in 
core and coating shell made from mixture of two different polymers were approved. One of 
the used polymers was water soluble, the second one water insoluble. The water insoluble 
plasticizer ranged from 0.1 to 15.0 % by weight in this composition (Nair et al., 2010).  
2.1.2 Mechanical properties of the coating improved by plasticizer 
Good flexibility of the coating is essential for insuring the resistance of the coating to the 
mechanical impact force expected during the coating process, and in the application place of 
the coated dosage form (particularly in the gastrointestinal tract). However, pure polymer 
coatings are often brittle. An addition of an external plasticizer to the polymeric networks 
will increase the flexibility of the coatings (Siepmann et al., 1999). 
The affirmative effect of the plasticizers on mechanical properties of the coating is caused by 
reducing of the cohesive intermolecular forces along the polymer chains. The flexibility is 
enhanced by increasing strain elongation and decreasing tensile strength and elastic 
modulus of the polymer (Gutierrez-Rocca & McGinity, 1994).  
For example, triethyl citrate, triacetin and acetyltriethyl citrate used as a water-soluble 
plasticizer of the hydroxypropylmethylcellulose acetate succinate in press-coated tablets for 
colon targeting formulation ensure the plastic deformation property of the outer shell due to 
some interaction between hydroxypropylmethylcellulose acetate succinate and triethyl 
citrate (Fukui et al., 2001). Plasticized polymeric coating with dispersed bioactive anti-
inflammatory and anti-thrombogenic drugs was applied for stents (Udipi & Cheng, 2004).  
2.1.3 Adhesion of coating influenced by plasticizer 
Good adhesion between a polymer and the surface of a solid is a major prerequisite for the 
film coating of pharmaceutical dosage forms. Loss of adhesion may reduce the functions 
that the film-coating provides to the solid substrate, particularly the mechanical protection 
that the coating ensures to the solid substrate and the drug release modified by coating. 
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There are two substantial forces which influence the polymer adhesion: the strength of the 
interfacial bonds between the polymeric film and the surface of the solid, and the internal 
stresses within the film coating. The interfacial bonding between the tablet surface and 
polymer coating is made primarily with hydrogen bonds, to a lesser extent with dipole-
dipole and dipole-induced dipole interactions. The addition of plasticizing agents to coating 
formulations generally decreases the internal stress in the film by decreasing both the elastic 
modulus and the glass transition temperature of the film coating (Johnson  Hathaway, 
1991; Rowe, 1981, 1992). 
The measured force of adhesion, therefore, would be expected to increase with increased 
plasticization of the polymer. The contradictory results may be due to the interaction of the 
plasticizing agent with the polar groups of the polymer within the film structure (Felton  
McGinity, 1999). 
The adhesive property of Eudragit films is effected with organic esters used as plasticizers 
(triacetin, diethyl phthalate, dibutyl phthalate and tributyl citrate were tested). The 
molecular weight and solubility parameters of the plasticizer seemed to play an important 
role in changing the adhesive strength of the Eudragit films. The adhesion of Eudragit films 
is markedly increased when the concentration of the plasticizer is greater than 25%. Tributyl 
citrate may be the best choice of the plasticizer for the Eudragit film, particularly for the 
Eudragit E film.  
The molecular weight and solubility parameters of the plasticizer seemed to play an 
important role in changing the adhesive strength of the Eudragit films (Lina et al., 2000).  
The water soluble plasticizers, triethyl citrate and polyethylene glycol 6000, lower the Tg of 
the films to a greater extent than the hydrophobic plasticizers, tributyl citrate and dibutyl 
sebacate, and the coatings with the hydrophilic plasticizers exhibit stronger adhesion 
(Entwistle  Rowe, 1979; Felton  McGinity, 1997).  
The study of the influence of plasticizers on the adhesion of the acrylic polymer to either 
hydrophilic or hydrophobic tablet compacts revealed that increasing tablet hydrophobicity 
decreased adhesion of both cellulosic and acrylic polymers (Felton  McGinity, 1996, 1997; 
Rowe, 1977). 
2.2 Factors negatively influencing the coating 
Polymer-plasticizer incompatibility, plasticizer migration out of polymer (and particularly 
leaching of plasticizer) as well sticking and aging of the film coated dosage influence not 
only the mechanical properties, but also drug release (Amighi  Moes, 1996; Arwidsson et 
al., 1991; Bodmeier  Paeratakul, 1992; Skultety  Sims, 1987). For example, dibutyl sebacate 
unlike triethyl citrate was found to remain within the polymeric coating upon exposure to 
the dissolution media and thus mechanical properties of coatings during drug release are 
maintained. Leaching of triethyl citrate out of the film resulting in decreased mechanical 
resistances facilitates crack formation.  
A blend of polymers can be used in the coating of solid dosage forms, and then the type of 
plasticizer must be chosen responsibly to ensure good quality of the coating. If the 
plasticizer has different affinities to the individual polymers forming the blend, the 
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plasticizer redistribution within the polymeric system during coating occurs. As an example 
can serve pellets coated with blends of ethyl cellulose and Eudragit® L. Dibutyl sebacate 
used as plasticizer of this coating shows a higher affinity to ethyl cellulose than to 
Eudragit® L (Lecomte et. al., 2004).  
3. Free membranes 
A membrane can be in the form of a free film containing the active ingredient, or it can form 
the outer wall of the body which is its reservoir together with other excipients. The 
membrane has a defined thickness; it can be porous or compact, it can contain, in addition to 
the active ingredient, various excipients including plasticizers. In the case of dosage forms 
such as buccal and sublingual films, capsules intended for oral, rectal or vaginal 
administration, and inserts placed into cavities, their membranes and membrane systems 
possess the function of (1) the primary coating increasing stability and enabling 
administration, (2) separation from and protection against the influence of the biological 
environment after administration, or (3) controlled release.  
Ethyl cellulose films of standard thickness were prepared by slow evaporation of the solvent 
from chloroform solutions of a 48.8% ethoxylated cellulose derivative and three plasticizers: 
classic dibutyl sebacate, vitamin D3 and vitamin E. The individual plasticizers were used in 
nine different concentrations up to 80 %. It has been demonstrated that primarily α-
tocopherol (vitamin E) in concentrations of 40 to 50 % is an advantageous and effective 
plasticizer of ethyl cellulose from the standpoint of toxicity, ultimate strength, toughness, 
and Young modulus (Kangarlou et al., 2008). Ethyl cellulose of the identical parameters was 
employed in the preparation of films using the same method, diethyl sebacate in a 40% 
concentration being used as the plasticizer. Chloroform was evaporated using the standard 
very slow evaporation procedure. A suitable velocity of stress action was found for the most 
conclusive stress-strain deformation diagrams (Sogol & Ismaeil, 2011). 
Thin films made of poly(lactide-co-glycolide) were prepared from a dichloromethane 
solution with additions of 15%, 25%, or 50% polyethylene glycol 8 000 and 35 000, 
yielding potential implants of 40 µm in thickness containing the antitumor drug 
paclitaxel. Raman spectrometry was used to demonstrate partial separation of the 
plasticizer (Steele et al., 2011). 
Soft gelatin capsules were formed by a wall of varying thickness containing about 40 to 45 % 
of gelatin, which is plasticized with water 20 to 30 % and glycerol, or sorbitol 30 to 35 % 
(Marques et al., 2009). The plasticizer increased the flexibility of gelatin, with increasing 
concentration to 45 % it decreased the sensitivity to humidity, decreased the tendency 
to recrystallization, decreased tensile strength and the elastic modulus, increases elongation 
at break (Bergo & Sobral, 2007). 
Protein films possess good mechanical properties, but they are very sensitive to atmospheric 
humidity. Their hygroscopic character can be decreased by adding a hydrophobic 
plasticizer. Esters derived from citric acid such as triethyl citrate, tributyl citrate, acetyl 
triethyl citrate and acetyl tributyl citrate were tested in various concentrations (Andreuccetti 
et al., 2009). Their limited miscibility with an aqueous solution of gelatin was solved by 
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emulsification of plasticizers with soya lecithin. The tensile stress of the material was 
decreased with increasing concentrations of the plasticizer, permeability of water vapours 
was moderately increased. 
Biodegradable films were prepared from a protein isolated from sunflower oil with 
additions of various polyalcohols, such as glycerol, ethylene glycol, propylene glycol, 
polyethylene glycols. The mixture was subjected to thermo-moulding at 150 °C using 
150 MPa. Tensile strength of films was 6.3 to 9.6 MPa and elongation at break was 23 to 
140 %. Permeability of water vapours was low; films were resistant against aqueous 
environment only in a limited degree, as migration of the plasticizer took place (Orliac et al., 
2003). The plasticizers used were evaluated as suitable for protein films. 
4. Polymeric membranes for transdermal system 
Transdermal systems are based on the adhesion of the system containing the active 
ingredient onto the intact skin and the transfer of the dissolved active ingredient through 
the skin. The limiting factor for the velocity of transdermal absorption is most frequently the 
thin membrane or a polymeric matrix structure. To fulfil the necessary precondition of the 
barrier principle as the controlling system of transdermal absorption, the velocity of 
permeation through the membrane or matrix must be lower than the velocity of penetration 
into the skin structures. Plasticizers are of extraordinary importance as they ensure not only 
suitable mechanical properties, in particular flexibility of the system, but also in connection 
with a decreased value of Tg increase the diffusivity of polymers. 
In the development of a suitable membrane for transdermal use, cellulose acetate casted 
from a chloroform solution was used. The polymer was plasticized with dibutyl phthalate, 
polyethylene glycol 600 and propylene glycol in a concentration of 40 %. The prepared 
membranes were characterized from the standpoint of mechanical properties, transfer of 
water vapours and permeability of diltiazem hydrochloride and indomethacin. Permeability 
of the active ingredient was the highest with the use of polyethylene glycol as the 
plasticizer, the lowest in the case of dibutyl phthalate (Rao & Diwan, 1997). The plasticizer 
of membranes from cellulose acetate was poly(caprolactone triol), and the pore forming 
agent was water (Meier et al., 2004). On the basis of testing the permeability of paracetamol, 
water was demonstrated to be a suitable porosigen with a possible regulation of porosity by 
its concentration, the plasticizer suitably acting as the modulator of permeation of the active 
ingredient. A combination of these two excipients yielded the membranes whose values of 
the coefficients of permeation of paracetamol ranged from 10-7 to 10-5 cm s-1. 
The matrix system from polyvinyl acetate containing polyethylene-2 oleyl ether as the 
enhancer of permeation and triethyl citrate as the plasticizer resulted in a significant 
increase in the bioavailability of the antihistamine drug triprolidine. The effect was 
demonstrated after the administration of the system to the abdominal rabbit skin (Shin & 
Choi, 2005). Roughness, mechanical and adhesive properties of skin patch were studied. An 
adhesive plaster was prepared from a blend of polyvinyl alcohol and polyvinylpyrrolidon 
with glycerol or polyethylene glycols 200 or 400 as the plasticizers. The adhesivity of the 
system was ascertained only in contact with wet surfaces. Glycerol in a concentration of 
10 % did not influence the very smooth texture of the surface of the plaster. The effect of the 
plasticizer was increased with decreasing molecular mass (Gal & Nussinovitch, 2009). 
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5. Matrix polymeric systems 
Matrix polymeric systems are heterogeneous systems composed of a polymer, plasticizers, 
other additives and the active ingredient, and they can be porous. They include primarily 
oral preparations with prolonged or retarded release of the active ingredient, or implants 
produced by extrusion or hot moulding or compression. 
Extrusion is a process of conversion of raw materials to form a product of a uniform shape 
and density by forcing it through a nozzle under controlled conditions (Breitenbach, 2002). 
Plasticizers facilitate the manufacture and improve the parameters of preparations such as 
porosity, tortuosity, mechanical resistance, diffusivity, or compatibility of the components. 
Hot-melt extrusion, in which it is possible to process materials with higher Tg values, is 
advantageous.  
Due to their little volatility, the plasticizers which are in the solid state in room temperature 
are advantageous. For plasticization of polyacrylate polymers, e.g. matrices from Eudragit 
RS PO, citric acid, in particular its monohydrate, turned out to be useful. Tensile strength 
and the elastic modulus were decreased, whereas elongation was increased. The plasticizing 
effect of citric acid achieved the plateau stage at its 25% concentration in polyacrylate, i.e. 
when achieving the solubility value of (Schilling et al., 2007). The continous process of 
extrusion and subsequent division of the extruded body into tablets was used in the 
formulation of enterosolvent preparations from the polyacrylate material Eudragit L100-55. 
Mixtures of two plasticizers, triethyl citrate and citric acid, were employed. Triethyl citrate 
markedly decreased the Tg value and thus decreased the temperatures in the individual 
zones of the extruder and the pressure during extrusion. The optimal concentration of citric 
acid was 17 %. 5-aminosalicylic acid was employed as the model active ingredient (Andrews 
et al., 2008). 
Subcutaneous implants of a diameter of 1.5 mm and length of 18 mm weighing 40 mg 
containing thermolabile recombinant proteins and peptides were prepared from plasticized 
poly(lactide-co-glycolide) as the carrier and ethanol as the plasticizer (Mauriac & Marion, 
2006). First, a 10% solution of the polymer in ethanol was prepared, followed by drying to 
achieve an ethanol concentration of 20 %. The polymer plasticized in such a way was mixed 
with the unplasticized one and the mixture was extruded at 75 °C. The following step was 
grinding of the extrudate at -5 to -10 °C with an ethanol content of 8 %. The active ingredient 
and other additives were added to the powder and the mixture was extruded at 
a temperature up to 70 °C. Another example of extremely volatile plasticizer is supercritical 
carbon dioxide (Lakshman, 2008). This compoud is added to facilitate processing of 
materials by extrusion method. 
Starch is the biomaterial which has excellent parameters from the standpoint of availability, 
price and biocompatibility. In the presence of water and suitable polar hydrophilic 
compatible plasticizers during extrusions at temperatures over 100 °C amylopectin flows 
and at the same time native starch granules partially melt. The material can have two 
markedly different values of Tg. Interactions between starch and plasticizers with strong 
hydrogen bonds (Pushpadass et al., 2008) were demonstrated in it. The use of glycerol in a 
concentration of 25 % and secondary plasticizers such as stearic acid, sucrose or urea in 
markedly lower concentrations are advantageous. It thus yields a flexible material suitable 
as a biodegradable drug carrier. 
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The matrix system containing a plasticized polymer can be also prepared by coating the 
pellets with a plasticized polymer and their subsequent compression to form tablets (Abdul 
et al., 2010). The use of a plasticizer does not require a curing step, which is heating after 
preparation. Pellets without a plasticizer are very brittle and break on compression. After an 
addition of 10 % triethyl citrate to the polymer Kollicoat SR30D (aqueous colloidal 
dispersion of polyvinyl acetate) the flexibility of the material was dramatically improved 
(Savicki & Lunio, 2005). 
6. In situ forming implants 
The classic medicated implants are the bodies of the solid state and of a defined shape, 
which are administered by an invasive surgical intervention into the muscular or other 
tissue. Their implantation requires local anaesthesia and a surgical intervention. In situ 
forming implants (ISFI) are liquid systems with a relatively low viscosity administered by 
an injection needle or a trocar containing a substance or several substances, which in the site 
of administration due to the biological environment spontaneously change its or their 
properties, in particular the mechanical ones. An important parameter is easy elimination 
capacity of systems based either on their biodegradability or slow dissolution (Hatefi & 
Amsden, 2002). The systems contain an active ingredient which is released from such 
implants in a long-term period, in the order of weeks to months. It thus enhances the effect 
of active ingredients, with decreased fluctuation of plasma concentrations toxicity is 
decreased, with decreased frequency of dosing the compliance of the patient is increased. 
Besides easy administration, an advantage of this relatively new dosage form is its simple 
manufacture. The systems find their use in human medicine, veterinary medicine 
(Winzenburg et al., 2004), and tissue engineering (Quaglia, 2008). 
ISFI are suitable for both local and systemic administration of substances with antimicrobial 
activity, antitumor substances, hormones, substances interacting with the immunity system, 
growth factors, etc. The importance of this mode of administration will be increased with 
the introduction of other medicinal substances of the protein type, as the structure of the 
implant can protect these substances against their enzymatic decomposition. 
The first system is named Atrigel Technology® and was patented in 1990 (Dunn et al., 1990; 
Warren et al., 2009). It is based on the administration of solutions of biodegradable polymers 
into the soft tissue. After administration, the water-soluble solvent is distributed into the 
surrounding tissue and the polymer is precipitated due to a backflow of aqueous solutions 
from the biological environment. The development of implants was studied in vivo using a 
non-invasive ultrasound imaging technique. The release of the active ingredient from implants 
has been demonstrated to be influenced not only by the composition of the surrounding 
pathologically changed tissue, but also by the mechanical conditions in it (Patel et al., 2010), 
and the process of precipitation of the polymer is considerably influenced by its molecular 
mass (Solorio et al., 2010). A system with continuous release of the immunoenhancer thymosin 
alpha 1 was constructed by dispersion of chitosan or albumin microparticles with this 
substance in the poly(lactide-co-glycolide) matrices dissolved in N-methyl-2-pyrrolidone. This 
achieved thymosin release for a period of 15 to 30 days (Liu et al., 2010). 
The problem of the system Atrigel Technology® is the toxicity of solvents and a sudden 
initial release of a substantial part of the total dose of the contained active ingredient. In 
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spite of it, in praxis there are antimicrobial and hormonal preparations based on this 
principle. The system based on the principle of rapid precipitation of the solutions of the 
biotechnological copolymer PHB/PHC in different solvents was employed to formulate ISFI 
of the film type acting preventively against adhesions of the tissues as undesirable 
phenomena in post-surgical applications (Dai et al., 2009).  
Other types of ISFI are three-block copolymers of ABA or BAB types based on the gelation 
of their solutions after administration due to increased temperatures. Oligomers composed 
of polyethylene glycol blocks and the blocks of polyesters of aliphatic hydroxy acids are 
advantageous (Quiao et al, 2007; Tang & Singh, 2009). An advantage of the system ReGel® is 
the absence of toxic organic solvents and a solubilizing potential of the block copolymer. In 
pharmacotherapeutic praxis the system ReGel® with paclitaxel called OncoGel® is employed 
(Matthes et al., 2007; ). For some active ingredients, some polymers and some modes of 
administration a too intensive burst effect, changes in the velocity of release of the active 
ingredient, or irritability of the polymer, which in the systems is used in higher 
concentrations, can occur (Packhaeuser et al., 2004).  
Instead of polymer solutions in hydrophilic solvents, hydrophobic solvents of lower 
concentrations than the polymer concentration can be employed. They are thus the 
plasticized polymers. The behaviour of the system after its administration into the tissue is 
different, the system is not distributed into the environment. The polymer and possibly the 
plasticizer are subject to biodegradation, the mechanism of the release of the active 
ingredient is due to the enzymatic or hydrolytic destruction of the implant. A sufficiently 
low viscosity can be achieved, besides the use of the plasticizer, by increasing the 
temperature of the applied system. The maximal painless temperature in humans is stated 
as 53 °C, the maximal tolerable temperature without necrotic changes is 60 °C (Liu & 
Wilson, 1998).  
The flowable composition relates to a sustained released delivery system with risperidone 
was patented. It may be injected into the tissue whereupon it coagulates to become the solid 
or gel, monolitic implant (Dadey, 2010). 
An in-situ-hardening paste, containing a biodagradable polymer and water soluble 
polymeric plasticizer was developed as delivery system for an active agent in the field of 
tissue regeneration. The hardened paste can be used as bone and cartilage replacement 
matrix (Hellebrand et. al., 2009). 
The following Table 1 presents a survey of hydrophobic plasticizers suitable for ISFI. 
Substance Melting point Boiling point 
Solubility 
in water [%] 
Benzyl alcohol -15 °C 205 °C 4.0 
Benzyl benzoate 70 °C 324 °C 1.5 x 10-5 
Ethyl heptanoate -66 °C 189 °C 3.0 x 10-4 
Propylene carbonate -55 °C 242 °C 17.5 
Triacetin 3 °C 258 °C 7.0 
Triethyl citrate -55 °C 235 °C /20 kPa 6.5 
Table 1. Characteristics of selected plasticizers with limited miscibility with water. 
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ISFI of this type use the protected name Alzamer® Depot technology (Alza Corporation) and 
are intended for subcutaneous administration. Thanks to the hydrophobic plasticizer, the 
systems possess a lower speed of degradation with a smaller burst and a slower release of 
the active ingredient (Matschke et al., 2002). Biocompatibility of plasticizers is higher than in 
the case of hydrophilic solvents. The advantage of most plasticizers of this type is their low 
volatility. Proteins and peptides are not dissolved in the systems, their suspensions are 
chemically very stable (Solanki et al., 2010). For a sufficiently decreased miscibility of ISFI of 
this type with the surrounding tissue liquid it is necessary to have the solubility of 
plasticizers in water lower than 7 % (Brodbeck et al., 2000). In situ forming thin membranes 
were prepared by mixing poly(lactide-co-glycolide) with 10 % polysorbate 80 as the 
plasticizer (Koocheki et al., 2011). 
7. Plasticized polymeric microparticles 
It is possible to differentiate two types of microparticles on the basis of their supramolecular 
texture. Microcapsules consist of a central part, which is called the core, and the peripheral 
part called the wall. The core contains the active ingredient; the wall is composed of the 
polymer. The microspheres are composed of a blend of a polymer and a suspended or 
dissolved active ingredient in the whole volume. The purpose of plasticization of polymers 
as the carriers of active ingredients in the microparticles is the modification of the kinetics of 
release either by changes in their hydrophilicity or lipophilicity, or a change in the Tg value, 
or a change in crystallinity. Release of active substances connected with these parameters of 
polymeric materials, and can be influenced by swelling, erosion, desorption, obstructive 
phenomena, osmotic phenomena, capillarity, etc. 
Microspheres from the blends of hydroxypropyl methylcellulose and ethylcellulose 
with metoprolol were plasticized with diethyl phthalate. With increasing concentration of 
the active ingredient, the velocity of release was decreased. Microparticles plasticized in 
a 5% concentration of the hydrophobic excipient possessed the velocity of release identical 
with that of the non-plasticized microspheres, an increase of the concentration of the 
plasticizer from 15 % to 20 % resulted in a significant increase in the velocity of release 
(Somwanshi et al., 2011). Indomethacin-loaded microspheres from poly(methyl 
methacrylate) intended for oral administration were prepared. The period of release of the 
active ingredient from non-plasticized microparticles was 8 h. After addition of triacetin, the 
release lasted for 24 h. Fourier transform infrared and nuclear magnetic resonance spectra 
demonstrated an interaction of the hydrogen type bonds between indomethacin and the 
polymer. No interaction was demonstrated between triacetin and indomethacin or the 
polymer (Yuksel et al., 2011).  
The liquid pharmaceutical formulations for oral administration with modified release of 
active principle, excluding amoxicillin was patented. Microcapsules prepared by 
microencapsulation of the active ingredient using proper polymer-plasticizer mixture were 
homogeneously dispersed into the external liquid phase (Castan et. al, 2011).  
In the course of release, the microspheres from poly(DL-lactide) were plasticized with water 
from the dissolution medium. Tg values rapidly decreased. At temperatures higher than Tg a 
rapid erosion of microspheres occurred, whereas at lower temperatures the polymer did not 
change for the period of the experiment (Aso et al., 1994). The microspheres from poly(L-
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lactide) and poly(lactide-co-glycolide) were obtained. After preparation using a standard 
solvent evaporation technique after freeze and oven drying these microparticles contained 
up to 3 % of water. Residual water markedly decreases Tg values according to Gordon-
Taylor relationship (Passerini & Craig, 2001). 
The microspheres intended for target oriented drug distribution were prepared 
from poly(lactic-co-glycolic acid) containing the chemotherapeutic agent etoposide in 
various concentrations. Plasticization with tricaprin in concentrations of 25 % and 50 % 
significantly increases the velocity of etoposide release in comparison with the microspheres 
without a plasticizer (Schaefer & Singh, 2002). The microcapsules containing the active 
ingredients soluble in water were prepared by the o/o/o emulsion method under the 
extraction of the solvent. Peanut oil was employed in the middle oily phase of multiple 
emulsion (Elkharraz et al., 2011). This peanut oil plasticized the internal phase containing a 
solution of the active ingredient and poly(DL-lactide) or poly(lactide-co-glycolide) .  
The velocity of release of the anticancer agent paclitaxel from poly(lactic-co-glycolic) 
microspheres was increased after addition of 30 % of isopropyl myristate, 70 % of the active 
ingredient was released within 3 weeks. After an increase in the concentration of the 
plasticizer to 50 % there was another increase in the velocity of the process. The plasticizer 
did not influence the course of degradation of polymers. Release of paclitaxel took place by 
the mechanism of diffusion from minimatrices (Sato et al., 1996). Analogous conclusions 
were published in a similar case of microspheres with etoposide (Schaefer & Singh, 2000). 
In situ forming microparticle systems are based on the emulsification of the solution of the 
active ingredient and polymer in the outer oily or aqueous phase. After the application of 
the emulsion there occurs separation of the solvent to the biological environment and 
solidification of the system. Besides water-soluble solvents it is possible to use the more 
hydrophobic, in a limited degree water soluble ones, which act as plasticizers. 
Myotoxicity of the plasticizers of this type is lower; the following series of decreasing 
toxicity was found: benzylalcohol > triethyl citrate > triacetin > propylene carbonate > 
ethyl acetate. Myotoxicity of ethyl acetate was comparable with the isotonic sodium 
chloride (Rungseevijitprapa et al., 2008). 
8. Bioadesive plasticized polymers 
Plasticized polymers play an unsubstitutable role in the formulation of the bioadhesive drug 
delivery systems (BDDS). Bioadhesive polymers have been formulated into tablets, patches, 
or microparticles, typically as a matrix into which the drug is dispersed, or as a barrier 
through which the drug diffuses (Ahuja et al., 1997).  
In most instances bioadhesive formulations are preferred over the conventional dosage 
forms, because bioadhesion allows the retention of the active substance in the place of 
application, or even absorption, and thus increases transmucosal fluxes. As mostly the 
hepatic first-pass metabolism is avoided, drug bioavailability may be enhanced. Target sites 
for bioadhesive drug delivery include the eye, GIT, oral cavity, nasal cavity, vagina, and 
cervix. The development of the adhesive dosage forms for controlled drug delivery to or via 
mucous membranes is of interest with regard to local drug therapy, as well the systemic 
administration of peptides and other drugs poorly absorbable from the gastrointestinal 
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tract. There is an important difference between the technical adhesion and bioadhesion; it is 
the presence of water, which is necessary for bioadhesion but impedes most technical 
applications. 
Similar to the plasticization mechanism also the mechanism of bioadhesion is usually 
analysed based on the polymer chains attractive and repulsive forces. Generally, 
bioadhesion is regarded as a two-step process. The first step is considered to be an 
interfacial phenomenon influenced by the surface energy effects and spreading process; a 
second step involves chain entanglement across a large distance, i.e. polymer chains show 
interdiffusion. Plasticizers can significantly influence both of these mentioned steps. 
According to the wetting theory of bioadhesion (Smart, 2005), there is a significant effect of 
the viscosity of the plasticized polymer on adhesivity. A plasticized polymer due to a lower 
viscosity has a higher ability to spread onto a surface as a prerequisite for the development 
of adhesion. 
The plasticizer reduces the aggregation process caused by the intermolecular attraction of 
the polymer, and it results in an increase in bioadhesiveness. The strength of bioadhesion 
should be sufficient, but not so sharp as to damage the biological tissue in the application 
site. The molecular weight, solubility parameter and concentration of the plasticizers used 
play an significant role. Further, a lower molecular weight or a higher concentration of 
plasticizers might lead to a greater plasticizing action (Qussi, & Suess, 2006).  
Since the strength of adhesion is dependent on the number and type of interfacial 
interactions, different polymers and the way of their plasticization will exhibit different 
adhesive properties depending on both the chemical structure and physico-chemical 
properties of the polymer, as well the plasticizer used. Many approved pharmaceutical 
excipients, which are well known and widely used, possess bioadhesive properties and are 
the first choice candidates for the formulation of bioadhesive preparations particularly due 
to easier registration.  
Bioadhesive materials are generally hydrophilic macromolecular compounds that contain 
numerous hydrogen bond forming groups, notably carboxyl, hydroxyl, amide and amine 
groups, and will hydrate and swell when placed in contact with an aqueous solution. Most 
often these materials need to hydrate to become adhesive but overhydration usually results 
in the formation of a slippery mucilage and loss of the adhesive properties (Peppas & 
Sahlin,1996). The invention provides mucoadhesive bioerodible, water soluble carriers for 
ocular delivery of pharmaceuticals for either systemic or local therapy (Warren et al., 2008). 
Plasticizer efficiency in bio/mucoadhesion is negatively influenced by inducing of the drug-
polymer interactions. In this case, the drug in BDDS is not only the active ingredient but 
represents an antiplasticizing additive responsible for the lowering of the adhesion strength. 
The triacetin-plasticized Eudragit E can serve as a film-forming material for the self-
adhesive drug-loaded film for transdermal application of piroxicam. Piroxicam did not 
represent only a simple model drug, it acts as an additive by molecularly dispersing it in the 
Eudragit E film. Drug-polymer interaction occurring between piroxicam and the Eudragit E 
film might be responsible for a decrease in adhesion strength. 
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In order to improve the flexibility and adhesiveness of the drug-loaded Eudragit E film 
plasticized with triacetin, secondary plasticizer can be supplemented. Polyethylene 
glycol 200, propylene glycol, diethyl phthalate, and oleic acid can serve as the secondary 
plasticizer to improve adhesion (Lin, et al., 1991, 1995).  
The adhesive properties were revealed in plasticized star-like branched terpolymers of 
dipentaeythritol, D,L-lactic acid and glycolic acids, where dipentaerythritol in concentration 
3 %, 5 % , or 8 % as the branching agent was used in the synthesis by polycondenzation. The 
common plasticizer, triethyl citrate, as well the non-traditional plasticizers methyl salicylate, 
ethyl salicylate, hexyl salicylate, and ethyl pyruvate were used (Fig. 1). These multi-
functional plasticizers can serve not only as plasticizers, but potentially pharmacodynamic 
efficient ingredients. 
Presently, there is still no universal test method for bioadhesion measurement. Tensile 
testing systems are the most widely used in-vitro method for assessing the strength of the 
bioadhesive interactions. The instrumental variables such as contact force, contact time and 
speed of withdrawal of probe from the substrate can affect the results of the adhesion 
measurements.  
The adhesiveness of the plasticized branched oligoesters was measured as the maximal 
force needed for the detachment of the adhesive material from the substrate, using the 
material testing machine Zwick/Roel T1-FR050TH.A1K (Snejdrova & Dittrich, 2009). The 
porcine stomach mucin gel served as a model substrate. All the plasticizers used provide 
high effectiveness in viscosity lowering, and thus a perfect spreading of the adhesive 
material on the contact surface as the prerequisite for good adhesion. Sufficient 
bioadhesion force was revealed in the wide range of dynamic viscosity (Fig. 2) (Snejdrova 
& Dittrich, 2008). 
 
Fig. 1. Adhesiveness of branched oligoester carriers of the drug influenced by plasticizer 
type and concentration: triethyl citrate (TEC), methyl salicylate (MS), ethyl salicylate (ES). 
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Fig. 2. Relation between viscosity and adhesivity of the branched oligoester carriers 
plasticized by various type and concentration of the plasticizers (triethyl citrate (TEC), 
methyl salicylate (MS), ethyl salicylate (ES). 
9. Conclusion 
The plasticization of polymers used in pharmaceutical technology can solve a lot of 
problems during the dosage forms formulation and can improve the quality of the final 
polymeric drug delivery system. The processing disadvantages can be thus overcome, or 
even a new technology can be enabled. The products of new quality are obtained by film 
coating of tablet with the thin layer of a plasticized polymer. The conventional film coating 
polymers mask the unpleasant organoleptic qualities of drug incorporated within the solid 
dosage form and protect the active drug substance from exposure to light, atmospheric 
moisture and oxygen. The functional coating polymers are used to modify the drug release 
profile, including the delayed release and sustained release. The membranes plasticized 
with suitable additive reaches the optimal parameters of permeability combined with the 
required drug release profile. Thanks to significant decrease of viscosity using the 
plasticizers, the in situ forming implants can be formulated and administered by an injection 
needle or a trocar. Multiparticulate dosage forms after incorporation of the proper 
plasticizer dispose of increased bioavailability.  
Plasticized polymers play the unsubstitutable role in the formulation of the bioadhesive 
drug delivery systems. The adhesive properties were revealed in plasticized star-like 
branched terpolymers of dipentaeythritol, D,L-lactic acid and glycolic acid. The 
multifunctional plasticizers methyl salicylate, ethyl salicylate, hexyl salicylate, and ethyl 
pyruvate can serve not only as plasticizers, but potentially also as pharmacodynamic 
efficient ingredients. In accordance with the spreading theory of bioadhesion, the decrease 
in viscosity resulted in improving of the bioadhesivity after addition of these plasticizers. 
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Pharmaceutically used 
polymer 
Plasticizer Applied as 
Cellulose nitrate 
(„collodion”) 
castor oil 
historically the first 
plasticized polymer 
used as a medicinal 
preparation  
(wounds covering) 
PVC 
di(2-ethylhexyl) phthalate, 
diisononyl phthalate,  
diisodecyl phthalate,  
epoxidized triglyceride,  
vegetable oils from soybean oil,  
linseed oil, castor oil,  
sunflower oil, fatty acid esters 
medical devices 
(bags, catheters, 
gloves, intravenous 
fluid containers, blood 
bags, medical tubings) 
Ethyl cellulose  dibutyl sebacate 
coatings  
free membranes 
Cellulose acetate 
dibutyl phthalate, PEG 600, 
propylene glycol,  
poly(caprolactone triol) 
polymeric membranes 
for transdermal 
system 
Blends of hydroxypropyl 
methylcellulose and 
ethylcellulose 
diethyl phthalate microparticles 
Cellulose acetate phthalate 
Cellulose acetate trimellitate  
Hydroxypropyl 
methylcellulose phthalate  
Polyvinyl acetate phthalate 
Shellac 
triacetin, acetylated monoglyceride, 
diethyl phthalate 
enteric or colonic drug 
delivery 
Hydroxypropyl 
methylcellulose acetate 
succinate 
triethyl citrate, triacetin, 
acetyltriethyl citrate 
press-coated tablets 
for colon targeting  
Blends of ethyl cellulose and 
Eudragit® L 
dibutyl sebacate enteric film coatings 
Chitosan salts 
(chloride, lactate, gluconate) 
glycerol, ethylenglycol, 
propylenglycol, PEGs 
free membrane 
Blend of native rice starch 
and chitosan 
sorbitol, glycerol, PEG 400 free membrane 
Thermoplastic starch 
Amylose 
Cassava starch 
polyhydric alcohols  
(glycerol, xylitol, sorbitol),  
secondary plasticizers  
(stearic acid, sucrose, urea) 
polymeric matrices 
Gelatin 
glycerol, sorbitol, mannitol, sucrose, 
citric acid, tartaric acid, maleic acid, 
PEGs 
free membranes 
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Pharmaceutically used 
polymer 
Plasticizer Applied as 
Whey protein 
Sunflower protein 
triethyl citrate, tributyl citrate, 
acetyl triethyl citrate, acetyl tributyl 
citrate, glycerol, ethylene glycol, 
propylene glycol, PEGs 
particulate systems 
Poly(lactic acid) 
Poly(lactide-co-glycolide) 
oligoesters or low-molecular 
polyesters, polyesteramides, 
PEGs, polypropylene glycol, 
blend of triacetin and oligomeric 
poly(1,3-butanediol), 
active ingredients (ibuprofen, 
theophylline, salts of metoprolol 
and chlorpheniramine), 
ethanol, polysorbate 80, 
water, tricaprin, peanut oil, 
isopropyl myristate 
free membranes 
polymeric matrices 
in situ forming 
systems 
microparticles 
Star-like branched 
terpolymers 
of dipentaeythritol, D,L-lactic 
acid and glycolic acids 
triethyl citrate, methyl salicylate, 
ethyl salicylate, hexyl salicylate, 
ethyl pyruvate 
bioadhesive drug 
delivery systems 
Copolymers of methacrylate 
esters ammoniated 
(Eudragit® E grades) 
tributyl citrate, triacetin, PEG 200, 
secondary plasticizer (propylene 
glycol, diethyl phthalate, oleic acid) 
moisture protection 
and odor/taste 
masking coatings 
bioadhesive drug 
delivery systems 
Copolymers of ethyl acrylate 
and methyl methacrylate 
(Eudragit® RL and RS grades) 
water (relative humidity), citric acid 
monohydrate, active ingredients 
(metoprolol tartrate, 
chlorpheniramine maleate), 
auxiliary compounds (surfactants, 
preservatives- methylparaben, 
solvents, cosolvents, desolvating 
and coacervating agents) 
time-controlled drug 
release 
polymeric matrices 
Poly(methyl methacrylate) 
Triacetin, supercritical carbon 
dioxide, dibutyl phthalate 
microparticles 
intraocular lenses 
hard contact lenses 
Blend of polyvinyl alcohol and 
polyvinylpyrrolidon 
glycerol, PEG 200 or 400 
polymeric membranes 
for transdermal 
system 
Kollicoat SR30D (aqueous 
colloidal dispersion of PVA) 
triethyl citrate polymeric matrices 
Various non-soluble polymers 
benzyl alcohol, benzyl benzoate, 
ethyl heptanoate, propylene 
carbonate, triacetin, triethyl citrate 
in situ implants 
Table 2. List of plasticized polymers reviewed in presented chapter. 
www.intechopen.com
 
Pharmaceutical Applications of Plasticized Polymers 
 
85 
10. References 
Abdul, S., Chandewar, A.V. & Jaiswal, S.B. (2010). A flexible technology for modified-release 
drugs: Multiple-unit pellet system (MUPS). Journal of Controlled Release, Vol.147, 
No.1, (October 2010), pp. 2-16, ISSN 0168-3659 
Ahuja, A., Khar, R. P. & Ali, J. (1997). Mucoadhesive Drug Delivery System. Drug 
Development & Industrial Pharmacy, Vol.23, No.5, (January 1997), pp. 489 – 515, ISSN 
1520-5762 
Amighi, K. & Moes, A. (1996). Influence of plasticizer concentration and storage conditions 
on the drug release rate from Eudragit® RS 30 D film-coated sustained-release 
theophylline pellets. European Journal of Pharmaceutics and Biopharmaceutics, Vol.42, 
No.1, pp. 29-35. ISSN 0939-6411 
Andreucatti, C., Carvalho, R.A. & Grosso, C.R.F. (2009). Effect of hydrophobic plasticizers 
on functional properties of gelatin-based films. Food Research International, Vol.42, 
No.8, (October 1994), pp. 1113-1121, ISSN 0963-9969 
Andrews, G.P., Jones, D.S., Diak, O.A., McCoy, C.P., Watts, A.B. & McGinity, J.W. (2008). 
The manufacture and characterization of hot-melt extruded enteric tablets. 
European Journal of Pharmaceutics and Biopharmaceutics, Vol.69, No.1, (May 2008), pp. 
264-273, ISSN 0939-6411 
Arwidsson, H., Hjelstuen, O., Ingason, D. & Graffner, C. (1991). Properties of ethyl cellulose 
films for extended release. Part 2. Influence of plasticizer content and coalescence 
conditions when using aqueous dispersions, Acta Pharmaceutica Nordica, Vol.3, 
No.2, pp. 65-70, ISSN 1100-1801 
Aso, Y., Yoshioka, S., Po, L.W. & Terao, T. (1994). Effect of temperature on mechanisms of 
drug release and matrix degradation of poly(DL-lactide) microspheres. Journal of 
Controlled Release, Vol.31, No.1, ( August 1994), pp. 33 – 39, ISSN 0168-3659 
Bergo, P. & Sobral, P.J.A. (2007) Effects of plasticizer on physical properties of pigskin 
gelatin films. Food Hydrocolloids, Vol. 21, No.8, (December 2007), pp. 1285-1289, 
ISSN 0268.005X 
Bodmeier, R. & Paeratakul, O. (1992). Leaching of water-soluble plasticizers from polymeric 
films prepared from aqueous colloidal polymer dispersions. Drug Delivery and 
Industrial Pharmacy, Vol.18, No.17, (January 1992), pp. 1865-1882, ISSN 1520-5762 
Breitenbach, J. (2002). Melt extrusion: from process to drug delivery technology. European 
Journal of Pharmaceutics and Biopharmaceutics, Vol.54, No.2, (September 2002), pp. 
107-117, ISSN 0939-6411 
Brodbeck, K.V., Gaynor-Duarte, A.T. & Shen, T.I. (2004). Gel compositions and methods, US 
Pat. No. 61032000 (March 21, 2000) 
Castan, C., Guimberteau, F. & Meyrueix, R. (2011). Oral pharmaceutical formulation in the 
form of aqueous suspension of microcapsules for modified release of amoxicillin. 
US Pat. No. 7,910, 133 B2 (May 25, 2006) 
Dadey, E. (2010). Sustained delivery formulations of risperidone compounds. US Pat. Appl. 
No. 20100266655 (October 21, 2010) 
Dai, Z.W., Zou, X.H. & Chen, G.Q. (2009). Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) 
as an injectable implant system for preventive of post-surgical tissue adhesion. 
Biomaterials, Vol.30, No.17, (June 2009), pp. 3075-3083, ISSN 0142-9612 
Dunn, R.L., English, P., Cowsar, D.R. & Vanderbilt, P. (1990). Biodegradable in-situ forming 
implants and methods of producing the same. US Pat. No. 4938763 (June 03, 1990) 
www.intechopen.com
 
Recent Advances in Plasticizers 
 
86
Fedorko, P., Djurado, D., Trznadel M., Dufour B., Rannou P. & Travers, J.P. (2003). 
Insulator–metal transition in polyaniline induced by plasticizers. Synthetic Metals, 
Vol.135–136, (April 2003), pp. 327–8, ISSN 0379-6779  
Felton, L.A. & McGinity, J.W. (1997). Influence of plasticizers on the adhesive properties of 
an acrylic resin copolymer to hydrophilic and hydrophobic tablet compacts. 
International Journal of Pharmaceutics, Vol.154, No.2, (August 1997), pp. 167–178, 
ISSN 0378-5173 
Felton, L.A. & McGinity, J.W. (1999). Adhesion of polymeric films to pharmaceutical solids. 
European Journal of Pharmaceutics and Biopharmaceutics, Vol.47, No.1, (January 1999), 
pp. 3–14, ISSN 0939-6411 
Felton, L.A., McGinity, J.W. (1996). Influence of tablet hardness and hydrophobicity on the 
adhesive properties of an acrylic resin copolymer. Pharmaceutical Development & 
Technology, Vol.1, No.4, (January 1996). pp. 381–389, ISSN 1083-7450 
Fukui, E., Miyamura, N., Yoneyama, T. & Kobayashi, M. (2001). Drug release from and 
mechanical properties of press-coated tablets with hydroxypropylmethylcellulose 
acetate succinate and plasticizers in the outer shell. International Journal of 
Pharmaceutics, Vol.217, No.1-2, (April 2001), pp. 33–43, ISSN 0378-5173 
Gal, A. & Nussinovich, A. (2009). Plasticizers in the manufacture of novel skin-bioadhesive 
patches. International Journal of Pharmaceutics, Vol.370, No.1-2, (March 2009), pp. 
103-109, ISSN 0378-5173 
Gutierrez-Rocca, J.C & McGinity, J.W. (1994). Infuence of water soluble and insoluble 
plasticizers on the physical and mechanical properties of acrylic resin copolymers. 
International Journal of Pharmaceutics, Vol.103, No.3, (March 1994), pp. 293-301, ISSN 
0378-5173 
Hatefi, A. & Amsden, B. (2002). Biodegradable injectable in situ forming drug delivery 
systems. Journal of Controlled Release, Vol.80, No.1-3, (April 2002), pp. 9-28, ISSN 
0168-3659 
Hellebrand, K., Seidler, M., Schütz, A., Pompe, C. & Friess, W. (2009). In situ hardening 
paste, its manufacturing and use. US Pat. Appl. No. 20090048145 (February 19, 
2009) 
Johnson, K., Hathaway, R., Leung, P. & Franz, R. (1991). Effect of triacetin and polyethylene 
glycol 400 on some physical properties of hydroxypropyl methycellulose free films. 
International Journal of Pharmaceutics, Vol.73, No.3, (July 1991), pp. 197–208, ISSN 
0378-5173 
Kangarlou, S.; Haririan, I. & Gholipour, Y. (2008). Physico-mechanical analysis of free ethyl 
cellulose films comprised with novel plasticizers of vitamin resources. International 
Journal of Pharmaceutics, Vol.356, No.1-2, (May 2008), pp. 153-166, ISSN 0378-5173 
Lakshman, J.P. (2008). Process for making pharmaceutical compositions with a transient 
plasticizer. US Pat. Appl. No. 20080280999 (November 13, 2008) 
Lecomte, F., Siepmann, J., Walther, M., MacRae, R.J. & Bodmeier, R. (2004). Polymer blends 
used for the aqueous coating of solid dosage forms: importance of the type of 
plasticizer. Journal of Controlled Release, Vol. 99, No.1, (September 2004) pp. 1– 13, 
ISSN 0168-3659 
Lehmann, K. (1992). Microcapsules and Nanoparticles in Medicine and Pharmacy, CRC Press, 
ISBN 0-8493-6986-X, Boca Raton, Florida 
www.intechopen.com
 
Pharmaceutical Applications of Plasticized Polymers 
 
87 
Lin, S.Y., Chau-Jen Lee, Ch.J. & Lin, Y.Y. (1995). Drug-polymer interaction affecting the 
mechanical properties, adhesion strength and release kinetics of piroxicam-loaded 
Eudragit E films plasticized with different plasticizers. Journal of Controlled Release, 
Vol.33, No.3, (March 1995), pp. 375-381, ISSN 0168-3659 
Lin, S.Y., Lee, Ch.J. & Lin., Y.Y. (1991). The effect of plasticizers on compatibility, mechanical 
properties, and adhesion strength of drug-free Eudragit E films. Pharmaceutical 
Research, Vol.8, No.9, (September 1991), pp. 1137-1143, ISSN 1573-904X  
Liu, F. & Wilson, B. C. (1998) Hyperthermia and photodynamic therapy, in: Tannock, I., Hill, R.P. 
(eds.), Basic Science of Oncology, McGraw-Hill, New York, 1998, pp. 443 – 453, ISBN 
0071053166 
Liu, Q., Zhang, H., Zhou, G., Xie, S., Zou, H., Yu, Y., Li, G., Sun, D., Zhang, G., Lu, Y. & 
Zhong, Y. (2010). In vitro and in vivo study of thymosin alpha 1 biodegradable in 
situ forming poly(lactide-co-glycolide) implants. International Journal of 
Pharmaceutics, 397, No.1-2, (September 2010), pp. 122-129, ISSN 0378-5173 
Marques, M.R.C., Cole, E., Kruep, D., Gray, V., Murachanian, D., Brown, W.E. & 
Giancaspro, G.I. (2009). Liquid-filled gelatin capsules. Pharmacopoeial Forum, Vol. 
35, No.4, pp. 1020-1041, USPC 
Matschke, Ch., Isele, U., van Hoogevest, P. & Ffahr, A. (2002). Sustained injectables formed 
in situ and their potential use for veterinary products. Journal of Controlled Release, 
Vol.85, No.1-3, (December 2002), pp. 1-15, ISSN 0168-3659 
Matthes, K., Mino-Knudson, D.V., Sahani, N., Holalkere, N., Fowers, K.D, Rathi, R. & 
Brugge, W.R. (2007). EUS guided injection of paclitaxel (OncoGel) provides 
therapeutic drug concentrations in the porcine pancreas. Gastrontestinal Endoscopy, 
Vol.65, No.3, (March 2007), pp. 448-453, ISSN 0016-5107 
Mauriac, P. & Marion, P. (2006). Use of ethanol as plasticizer for preparing subcutaneous 
implants containing thermolabile active principles dispersed on a plga matrix. US 
Pat. Appl. No. 20060171987 (July 24, 2004) 
Meier, M.M., Kanis, L.A., Solodi, V. (2004). Characterisation and drug-permeation profiles of 
microporous and dense cellulose acetate membranes: influence of plasticizer and 
pore forming agent. International Journal of Pharmaceutics, Vol.278, No.1, (June 2004), 
pp. 99 -110, ISSN 0378-5173 
Nair, R., Rajheja, P., Wang, S. & Pillai, R.S. (2010). Pseudoephedrine pharmaceutical 
formulations. US Pat. Appl. No. 20100260842 (October 14, 2010) 
Orliac, O., Rouilly, A., Silvestre, F. & Rigal, L. (2003). Effects of various plasticizers on the 
mechanical properties, water resistance and aging of thermo-moulded films made 
from sunflower proteins. Industrial Crops and Products, Vol.18, No.2, (September 
2003), pp. 91-100, ISSN 0926-6690 
Paborji, M. & Flugel, R.S. (2011). Pharmaceutical formulations for the treatment of 
overactive bladder. US Pat. Appl. No. 20110244051 (June 10, 2011) 
Packenheuser, C.B., Schnieders, J., Oster, C.G. & Kissel, T. (2004). In situ forming parenteral 
drug delivery system: an overview. European Journal of Pharmaceutics and 
Biopharmaceutics, Vol.58, No.2, (September 2004), pp. 445-455, ISSN 0939-6411 
Passerini, N. & Craig, D. Q. M. (2001). An investigation into the effects of residual water on 
the glass transition termperature of polylactide microspheres using modulated 
temperature DSC. Journal of Controlled Release, Vol.73, No.1, ( August 1994), pp. 111-
115, ISSN 0168-3659 
www.intechopen.com
 
Recent Advances in Plasticizers 
 
88
Patel, R.B., Solorio, L., Wu, H., Krupka, T. & Exner, A.A. (2010). Effect of injection site on in 
situ implant formation and drug release in vivo. Journal of Controlled Release, 
Vol.147, No.3, (November 2010), pp. 350-358, ISSN 0168-3659 
Peppas, N.A. & Sahlin, J.J. (1996). Hydrogels as mucoadhesive and bioadhesive materials: a 
review. Biomaterials, Vol. 17, No.16, 1996, pp. 1553-1561, ISSN 0142-9612 
Porter, S.C. (1995). The Coating of Pharmaceutical Dosage Forms, In: The Science and Practice 
of Pharmacy, J.P. Remington, A.R. Gennaro, (Eds.), 1650-1659, Mack Pub., ISBN 
0912734043, Easton, Pensylvania 
Pushpadass, H.A., Marx, D.B. & Hanna, M. A. (2008). Effects of extrusion temperature and 
plasticizers on the physical and functional properties of starch films. Starch/Stärke, 
Vol.60, No.10, (October 2008), pp. 527-538, ISSN 1521-379X 
Quaglia, F. (2008). Bioinspired tissue engineering: The great promise of protein delivery. 
International Journal of Pharmaceutics, Vol.364, No.2, (December 2008), pp. 281-297, 
ISSN 0378-5173 
Quiao, M., Chen, D., Hao, T., Zhao, X., Hu, H. & Ma, X. (2007). Effect of bee venom peptide-
copolymer interactions on thermosensitive hydrogel delivery systems. International 
Journal of Pharmaceutics Vol.345, No.1-2, (December 2007), pp. 116-124, ISSN 0378-
5173 
Qussi, B., Suess, W. G. (2006). The Influence of Different Plasticizers and Polymers on the 
Mechanical and Thermal Properties, Porosity and Drug Permeability of Free 
Shellac Films. Drug Development & Industrial Pharmacy, Vol.32, No.4, (January 2006), 
pp. 403 – 412, ISSN 1520-5762 
Rao, P.R. & Divan, P.V. (1997) Permeability studies of cellulose acetate free films for 
transdermal use: Influence of plasticizers. Pharmaceutica Acta Helvetiae, Vol.72, No.1, 
(February 1997), pp. 47-51, ISSN 0031-6865 
Rowe, R.C. (1977). The adhesion of film coatings to tablet surfaces - the effect of some direct 
compression excipients and lubricants. Journal of Pharmacy and Pharmacology, Vol.29, 
No.1, (September 1977), pp. 723–726, ISSN 2042-7158 
Rowe, R.C. (1981). The adhesion of film coatings to tablet surfaces - a problem of stress 
distribution. Journal of Pharmacy and Pharmacology, Vol.33, No.1 (September 1981), 
pp. 610–612, ISSN 2042-7158. 
Rowe, R.C. (1992). Defects in film-coated tablets: Etiology and solutions, In: Advances in 
Pharmaceutical Sciences, D. Ganderton, T. Jones (Eds.), 65–99, Academic Press, ISBN, 
New York, USA 
Rungseevijitprapa, W., Brazeau, G.A., Simkins, J.W. & Bodmeier, R. (2008). Myotoxicity 
studies of O/W-in situ forming microparticle systems. European Journal of 
Pharmaceutics and Biopharmaceutics, Vol. 69, No.1 (May 2008) pp. 126 – 133, ISSN 
0939-6411 
Sato, Y. M., Wang, Y.M., Adachi, I. & Horikoshi, I. (1996). Pharmacokinetic study of taxol-
loaded poly(lactic-co-glycolic acid) microspheres containing isopropyl myristate 
after targeted delivery to the lung in mice. Biological & Pharmaceutical Bulletin, 
Vol.19, No.12 (December 1996), ISSN 0918-6158 
Sawicki, W. & Lunio, R. (2005). Compressibility of floating pellets with verapamil 
hydrochloride coated with dispersion Kollicoat SR 30 D. European Journal of 
Pharmaceutics and Biopharmaceutics, Vol.60, No.1 (May 2005), pp.153 – 158, ISSN 
0939-6411 
www.intechopen.com
 
Pharmaceutical Applications of Plasticized Polymers 
 
89 
Shin, S.-Ch. & Choi, J.-S. (2005). Enhanced efficacy of triprolidine by transdermal application 
of the EVA matrix system in rabbits and rats. European Journal of Pharmaceutics and 
Biopharmaceutics, Vol.61, No. 1-2, (September 2005), pp.14-19, ISSN 0939-6411 
Schaefer, M. J. & Singh, J. (2000). Effect of isopropyl myristic acid ester on the physical 
characteristics and in vitro release of etoposide from PLGA microspheres. AAPS 
PharmSciTech, Vol.1, No.4, Article 32 (November 2000), ISSN 1530-9932 
Schaefer, M. J. & Singh, J. (2002). Effect of tricaprin on the physical characteristic and in vitro 
release of etoposide from PLGA microspheres. Biomaterials, Vol.23, No.16 (August 
2002), pp. 3465 – 3471, ISSN 0142-9612 
Schilling, S.U., Shah, N.H., Malick, A.W., Infeld, M.H. & McGinity, J.W. (2007). Citric acid as 
a solid-state plasticizer for Eudragit RS PO. Journal of Pharmacy and Pharmacology, 
Vol.69, No.11, (November 2007), pp. 1493–1500, ISSN 0022-3573 
Siepmann, J., Lecomte, F. & Bodmeier, R. (1999). Diffusion-controlled drug delivery systems: 
calculation of the required composition to achieve desired release profiles. Journal of 
Controlled Release, Vol.60, No.3, (June 1999), pp. 379–389., ISSN 0168-3659 
Skultety, P.F. & Sims, S.M. (1987). Evaluation of the loss of propylene glycol during aqueous 
film coating. Drug Delivery and Industrial Pharmacy, Vol.13, No.12, (January 1987), 
pp. 2209-2219, ISSN 1520-5762 
Smart, J.D. (2005). The basics and underlying mechanisms of mucoadhesion. Advanced Drug 
Delivery Reviews. Vol.57, No.11, (November 2005), pp. 1556– 1568, ISSN 0169-409X 
Snejdrova, E. & Dittrich, M. (2009). Adhesivity of branched plasticized oligoesters. Ceska a 
Slovenska Farmacie, Vol.58, No.5-6, (December 2009), pp. 212 – 215, ISSN 1210-7816 
Snejdrova, E. & Dittrich, M. (2008). The reological properties of plasticized branched 
oligoesters. Folia Pharmaceutica Universitatis Carolinae, Vol.XXXVII, pp. 21-25, ISSN 
1210-9495 
Sogol, K. & Ismaeil, H. (2011). Mechanical influence of static versus dynamic loadings on 
parametrical analysis of plasticized ethyl cellulose films. International Journal of 
Pharmaceutics, Vol.408, No.1-2, (April 2011), pp. 1-8, ISSN 0378-5173 
Solanki, H.K., Thakkar, J.H. & Jani, G.K. (2010). Recent advances in implantable drug 
delivery. International Journal of Pharmaceutical Sciences Review and Research, Vol.4, 
No.3, Article 028, pp. 168-177, ISSN 0976-044X 
Solorio, L., Babin, B.M., Patel, R.b., Mach, J., Azar, N. & Exner, A.A. (2010). Noninvasive 
characterisation of in situ forming implants using diagnostic ultrasound. Journal of 
Controlled Release, Vol.143, No.2, (April 2010), pp. 183-190, ISSN 0168-3659 
Somwanshi, S. B., Dolas, R.T., Nikam, V.K., Gaware, V.M., Kotade, K.B., Dhamak, K.B., 
Khadse, A.N. & Kashid, V.A. (2011). Effects of drug-polymer ratio and plasticizer 
concentration on the release of metoprolol polymeric microspheres. International 
Journal of Pharmaceutical Research and Development, Vol.3, No.3, (May 2011), pp. 139 – 
146, ISSN 0974-9446 
Steele, T. W. J., Huang, Ch.L., Widjaja, E., Boey, F.Y.C., Loo, J.S.C. & Venkatraman, S.S. 
(2011). The effect of polyetylene glycol structure on paclitaxel drug release and 
mechanical properties of PLGA thin films. Acta Biomaterialia, Vol.7, No.5, ( May 
2011), pp. 1973-1983, ISSN 1742 - 7061 
Tang, Y. & Singh, J. (2009). Biodegradable and biocompatible thermosensitive polymer 
based injectable implant for controlled release of protein. International Journal of 
Pharmaceutics, Vol.365, No.1-2, (January 2009), pp. 34-43, ISSN 0378-5173 
www.intechopen.com
 
Recent Advances in Plasticizers 
 
90
Udipi, K. & Cheng, P. (2004). Plasticized stent coatings. US Pat. Appl. No. 0215336 (October 
28, 2004) 
Warren, S.L., Dadey, E., Dunn, R.L., Downing, J.M. & Li, E.Q. (2009). Sustained delivery 
formulations of octreotide compounds. US Pat. Appl. No. 20090092650 (April 09, 
2009) 
Warren, S.L., Osborne, D.W. & Holl, R. (2008). Adhesive bioerodible ocular drug delivery 
system. US Pat. Appl. No. 20080268021 (October 30, 2008) 
Winzenburg, G., Schmidt, C., Fuchs, S. & Kissel, T. (2004). Biodegradable polymers and their 
potential use in parenteral veterinary drug delivery systems. Advanced Drug 
Delivery Reviews, Vol.56, (February 2004), pp. 1453-1466, ISSN 0169-409X 
Yuksel, N., Baykara, M., Shirinzade, H. & Suzen, S. (2011). Investigation of triacetin effect on 
indomethacin release from poly(methyl methacrylate) microspheres: Evaluation of 
interactions using FT-IR and NMR spectroscopies. International Journal of 
Pharmaceutics, Vol.404, No.1-2 (February 2011), pp. 102-109, ISSN 0378-5173 
Zhu, Y., Shah, N.H., Malick, A.W., Infeld, M.H. & McGinity, J.W. (2002). Solid-state 
plasticization of an acrylic polymer with chlorpheniramine maleate and triethyl 
citrate. International Journal of Pharmaceutics, Vol. 241, No.2, (July 2002) pp. 301–310, 
ISSN 0378-5173 
www.intechopen.com
Recent Advances in Plasticizers
Edited by Dr. Mohammad Luqman
ISBN 978-953-51-0363-9
Hard cover, 212 pages
Publisher InTech
Published online 21, March, 2012
Published in print edition March, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Plasticizers are used to increase the process-ability, flexibility, and durability of the material, and of course to
reduce the cost in many cases. This edition covers introduction and applications of various types of plasticizers
including those based on non-toxic and highly effective pyrrolidones, and a new source of Collagen based bio-
plasticizers that can be obtained from discarded materials from a natural source; Jumbo Squid (Dosidicus
gigas). It covers the application of plasticizers in plastic, ion-selective electrode/electrochemical sensor,
transdermal drug delivery system, pharmaceutical and environmental sectors. This book can be used as an
important reference by graduate students, and researchers, scientists, engineers and industrialists in polymer,
electrochemical, pharmaceutical and environmental industries.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Eva Snejdrova and Milan Dittrich (2012). Pharmaceutical Applications of Plasticized Polymers, Recent
Advances in Plasticizers, Dr. Mohammad Luqman (Ed.), ISBN: 978-953-51-0363-9, InTech, Available from:
http://www.intechopen.com/books/recent-advances-in-plasticizers/pharmaceutical-applications-of-plasticized-
polymers
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
